David Schwartz
Overview
Explore the profile of David Schwartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
242
Citations
4167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colevas A, Cmelak A, Pfister D, Spencer S, Adkins D, Birkeland A, et al.
J Natl Compr Canc Netw
. 2025 Feb;
23(2):2-11.
PMID: 39938471
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary...
2.
Epchtien R, Temkin E, Masarwa S, Cohen A, Kaplan E, Schwartz D, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Feb;
PMID: 39928252
We evaluated whether skin sampling with E-swabs is an effective alternative to pre-moistened sponges for detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage. Skin samples were collected by sponges with enrichment and...
3.
Epchtien R, Temkin E, Lurie-Weinberger M, Kastel O, Keren-Paz A, Schwartz D, et al.
Microbiol Spectr
. 2025 Jan;
13(2):e0207924.
PMID: 39807863
Importance: Selective screening plates for carbapenemase-producing Enterobacterales (CPE) are used to detect CPE carriers for infection control purposes. We characterized non-CPE isolates that grew on selective CPE screening plates, which...
4.
Schwartz D, Zhang M, Troop-Gordon W, Taylor L, Chung J
J Adolesc
. 2024 Nov;
PMID: 39543815
Background: Popularity in adolescence has been the subject of considerable empirical inquiry over the last two decades. As research on this dimension of social experience evolved, fundamental shifts occurred in...
5.
Pollock J, Watson N, Pittman L, Schwartz D
Allergy Asthma Proc
. 2024 Nov;
45(6):453-455.
PMID: 39517077
Various formulations of dog allergen extracts, including conventional dog (also known as dog epithelium) and acetone precipitated (AP) dog, have been used for skin-prick testing (SPT), with AP dog showing...
6.
-producing ST654 comprises a quarter of all carbapenem-resistant in blood isolates from 15 hospitals
Kon H, Lurie-Weinberger M, Bechor M, Temkin E, Kastel O, Schwartz D, et al.
Antimicrob Agents Chemother
. 2024 Oct;
68(12):e0096524.
PMID: 39480074
Carbapenem-resistant (CRPA) are of major clinical concern. We analyzed 85 . blood isolates non-susceptible to carbapenems collected during 2021-2023 from 15 medical centers in Israel. We aimed to determine the...
7.
Rakovitsky N, Lurie-Weinberger M, Temkin E, Hameir A, Efrati-Epchtien R, Wulffhart L, et al.
Microbiol Spectr
. 2024 Oct;
:e0089124.
PMID: 39440983
There is an urgent need for accurate and fast diagnostic tests to identify carbapenemase-producing bacteria. Here, we evaluated a colorimetric imipenem hydrolysis test, called the CARBA PAcE test, to detect...
8.
Hostler C, Krishnan J, Parish A, Baroco A, Cooper P, Donceras O, et al.
Infect Control Hosp Epidemiol
. 2024 Oct;
:1-6.
PMID: 39363596
Objective: To evaluate postoperative outcomes among patients undergoing colon surgery who receive perioperative prophylaxis with ertapenem compared to other antibiotic regimens. Design And Setting: Multicenter retrospective cohort study among adults...
9.
Liu Y, Svennersten K, Schwartz D, Huss F, Falk-Delgado A
JPRAS Open
. 2024 Sep;
42:162-169.
PMID: 39328364
Background: Nitrous oxide (NO) use in recreational settings has been increasing in Sweden and Europe and consequently, the related injuries are also increasing. We aimed to investigate the incidence, management,...
10.
Colombel J, Lacerda A, Irving P, Panaccione R, Reinisch W, Rieder F, et al.
Clin Gastroenterol Hepatol
. 2024 Sep;
PMID: 39326583
Background & Aims: Efficacy of upadacitinib, an oral Janus kinase inhibitor, for moderate-to-severe Crohn's disease was demonstrated in phase 3 induction (U-EXCEL, U-EXCEED) and maintenance (U-ENDURE) trials; this post hoc...